Syndecan-1 promotes the angiogenic phenotype of multiple myeloma endothelial cells

Antibody-maytansinoid conjugates for the treatment of myeloma

(2010) Robert J. Lutz et al.   mAbs

Targeting EXT1 reveals a crucial role for heparan sulfate in the growth of multiple myeloma

(2009) R. M. Reijmers et al.   BLOOD

The Monoclonal Antibody nBT062 Conjugated to Cytotoxic Maytansinoids Has Selective Cytotoxicity Against CD138-Positive Multiple Myeloma Cells In vitro and In vivo

(2009) H. Ikeda et al.   CLINICAL CANCER RESEARCH

Gene Expression Profiling of Bone Marrow Endothelial Cells in Patients with Multiple Myeloma

(2009) R. Ria et al.   CLINICAL CANCER RESEARCH

Syndecan-1 Is Required for Robust Growth, Vascularization, and Metastasis of Myeloma Tumorsin Vivo

(2009) Yekaterina B. Khotskaya et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Inhibition of CD40–CD154 costimulatory pathway by a cyclic peptide targeting CD154

(2008) Ilaria Deambrosis et al.   JOURNAL OF MOLECULAR MEDICINE-JMM